Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Acadia Pharmaceuticals’ has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial.
Gilead has acquired the rights to three of Novartis’ preclinical antiviral programmes, including investigational compounds with the potential to...
This week's top 10 stories on Pharmafile.com
The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” has been made in pushing for...
Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (...
The decision covers its use in cardiac magnetic resonance imaging to determine patient levels of myocardial perfusion and late gadolinium...
Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the...
Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused the...
GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at promoting...
Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches